MUEL Mueller Paul Co Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
23:54
Aug 23
Aug 23
Microcap coverage list, no current directional view
Author lists microcap names previously covered by GeoInvesting as non-promotional companies, framing them as credible coverage candidates rather than current recommendations or positions.
LOW
20:35
Aug 02
Aug 02
MUEL long on pharma on-shoring demand surge
Buy MUEL on pullbacks; the OTC company has improved capital allocation, refocused on pharma markets, and stands to benefit from pharma on-shoring trends driving demand, with capacity expansion spend creating near-term volatility but long-term upside.
MED
23:35
Jul 27
Jul 27
Buy MUEL on a multi-year capital allocation transformation — successive tender offers.
Buy MUEL on a multi-year capital allocation transformation — successive tender offers, capacity expansion, pension liability removal, non-core asset sales, and a pivot toward higher-growth pharma and data center markets; contract management missteps in recent quarters are flagged as a near-term risk but viewed as anomalous, with normalized EPS potentially reaching $15–$20/quarter.
MED
02:33
May 08
May 08
Long $MUEL — GeoInvesting model portfolio holding.
Long $MUEL — GeoInvesting model portfolio holding; multiple successful tender offers since 2024 (latest $440/share, prior at $80/$250/$485) signal strong value realization, with upcoming capacity expansions to contribute soon.
MED
About MUEL Analyst Coverage
Buzzberg tracks MUEL (Mueller Paul Co) across 1 sources. 3 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (75%). 4 total trade ideas tracked. Past 7 days: 1 watch. Latest voices: majgeoinvesting.